| Year |
Citation |
Score |
| 2015 |
Hsieh J, Trajcevski KE, Farr SL, Baker CL, Lake EJ, Taher J, Iqbal J, Hussain MM, Adeli K. Glucagon-like peptide 2 (GLP-2) stimulates postprandial chylomicron production and post-absorptive release of intestinal triglyceride storage pools via induction of nitric oxide signalling in male hamsters and mice. Endocrinology. EN20151110. PMID 26132919 DOI: 10.1210/En.2015-1110 |
0.581 |
|
| 2014 |
Koseki M, Hsieh J, Yakushiji E, Welch C, Iqbal J, Hussain M, Takiguchi S, Rader D, Sakata Y, Yamashita S, Tall A. TTC39B deficiency promotes HDL production and impairs non-hdl absorption in small intestine Atherosclerosis. 235: e104. DOI: 10.1016/J.Atherosclerosis.2014.05.279 |
0.325 |
|
| 2013 |
Hein GJ, Baker C, Hsieh J, Farr S, Adeli K. GLP-1 and GLP-2 as yin and yang of intestinal lipoprotein production: evidence for predominance of GLP-2-stimulated postprandial lipemia in normal and insulin-resistant states. Diabetes. 62: 373-81. PMID 23028139 DOI: 10.2337/Db12-0202 |
0.62 |
|
| 2012 |
Hsieh J, Adeli K. Regulation of intestinal chylomicron production by glucagon-like peptides. Cardiovascular & Hematological Disorders Drug Targets. 12: 92-7. PMID 23030446 DOI: 10.2174/1871529X11202020092 |
0.629 |
|
| 2011 |
Xiao C, Hsieh J, Adeli K, Lewis GF. Gut-liver interaction in triglyceride-rich lipoprotein metabolism. American Journal of Physiology. Endocrinology and Metabolism. 301: E429-46. PMID 21693689 DOI: 10.1152/Ajpendo.00178.2011 |
0.548 |
|
| 2011 |
Warnakula S, Hsieh J, Adeli K, Hussain MM, Tso P, Proctor SD. New insights into how the intestine can regulate lipid homeostasis and impact vascular disease: frontiers for new pharmaceutical therapies to lower cardiovascular disease risk. The Canadian Journal of Cardiology. 27: 183-91. PMID 21459267 DOI: 10.1016/J.Cjca.2010.12.020 |
0.569 |
|
| 2010 |
Hsieh J, Longuet C, Baker CL, Qin B, Federico LM, Drucker DJ, Adeli K. The glucagon-like peptide 1 receptor is essential for postprandial lipoprotein synthesis and secretion in hamsters and mice. Diabetologia. 53: 552-61. PMID 19957161 DOI: 10.1007/S00125-009-1611-5 |
0.57 |
|
| 2010 |
Hsieh J, Baker CL, Adeli K. Glucagon-Like Peptide-2-Stimulated Intestinal Fat Absorption is Dependent on Nitric Oxide Synthase Atherosclerosis Supplements. 11: 76. DOI: 10.1016/J.Atherosclerosissup.2010.04.028 |
0.551 |
|
| 2010 |
Hsieh J, Adeli K. Glucagon-like Peptides (GLP-1 and GLP-2) as Ying and Yang of Intestinal Lipid Absorption and Chylomicron Production Atherosclerosis Supplements. 11: 67. DOI: 10.1016/J.Atherosclerosissup.2010.04.012 |
0.608 |
|
| 2009 |
Hsieh J, Longuet C, Maida A, Bahrami J, Xu E, Baker CL, Brubaker PL, Drucker DJ, Adeli K. Glucagon-like peptide-2 increases intestinal lipid absorption and chylomicron production via CD36. Gastroenterology. 137: 997-1005, 1005.e1-4. PMID 19482026 DOI: 10.1053/J.Gastro.2009.05.051 |
0.618 |
|
| 2008 |
Hsieh J, Hayashi AA, Webb J, Adeli K. Postprandial dyslipidemia in insulin resistance: mechanisms and role of intestinal insulin sensitivity. Atherosclerosis. Supplements. 9: 7-13. PMID 18653387 DOI: 10.1016/J.Atherosclerosissup.2008.05.011 |
0.596 |
|
| 2008 |
Baker C, Naples M, Hsieh J, Adeli K. Sitaglipin treatment attenuates triglyceride rich lipoprotein accumulation in fructose fed syrian gold hamsters Atherosclerosis Supplements. 9: 89. DOI: 10.1016/J.Atherosclerosissup.2008.09.409 |
0.47 |
|
| 2008 |
Hsieh J, Longuet C, Xu E, Baker C, Brubaker P, Drucker D, Adeli K. Glucagon-like peptide-2 (GLP-2) is a potent mediator of intestinal ApoB48-containing lipoprotein overproduction Atherosclerosis Supplements. 9: 84-85. DOI: 10.1016/J.Atherosclerosissup.2008.09.400 |
0.596 |
|
| Show low-probability matches. |